Treatment of cerebral thrombosis: first, thrombolytic therapy, thrombolytic therapy can be considered within the time window of cerebral infarction, and rt-PA and urokinase are commonly used for thrombolytic therapy in China. Second, antiplatelet aggregation therapy: for patients with ischemic stroke who do not meet the indications for thrombolysis and have no contraindications to antiplatelet agents, oral aspirin should be given as early as possible after onset. For patients with non-cardiogenic mild cerebral infarction without contraindications within 24 hours of onset, dual antiplatelet therapy with aspirin combined with clobigrel should be given as early as possible, with the duration of dual anti-treatment not exceeding three weeks. Third, fibre-lowering therapy. Fibrin-lowering therapy can be considered for patients with cerebral infarction who are not suitable for thrombolysis and have undergone strict screening, especially those with hyperfibrinemia can be used, and the commonly used drug bactrim. Fourth, neuroprotective therapy. Mainly edaravone treatment, an antioxidant and free radical scavenger. Fifth, butalbital therapy, butalbital can improve the establishment of collateral circulation, which is effective for patients with cerebral infarction. Sixth, to prevent plaque detachment and lower blood lipids, statins such as atorvastatin and simvastatin can be used. Seventh, lowering blood sugar and blood pressure treatment, according to the corresponding disease situation reasonable planning of antihypertensive and hypoglycemic drugs. Eighth, blood circulation and nerve nutrition. Such as methylcobalamin, Chinese patent medicine, etc. Quit smoking and alcohol. Be sure to go to the hospital for formal examination and treatment, regular review, and a low-salt, low-fat, low-sugar diet.